Biogen (NASDAQ:BIIB) said on Wednesday that the U.S. FDA has granted Fast Track designation to BIIB080, its antisense ...
About 1 in 3 Americans will get shingles, according to the Centers for Disease Control and Prevention. While most recover, it ...
A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...
The explanation of Alzheimer's, given the span of the disease, could become more of an ongoing process for the child rather ...
Eli Lilly & Co. is adding Alzheimer’s disease resources to the online platform it launched a year ago to sell obesity, ...
1d
News-Medical.Net on MSNA new blood test could improve how Alzheimer’s disease is diagnosedThe blood test for eMTBR-tau243 shows strong correlation with tau pathology, enhancing Alzheimer's diagnosis and monitoring ...
Deficits in slow-wave and REM sleep appear to shrink parts of the brain known to be early indicators of cognitive deterioration and Alzheimer’s disease, said lead study author Gawon Cho ...
While Alzheimer’s disease is typically marked by a slow decline in memory and cognitive ability over a number of years, a ...
The probiotic-rich drink kefir may be a potential complementary treatment for Alzheimer’s disease by helping improve ...
BIIB080 is an antisense oligonucleotide therapy designed to target microtubule-associated protein tau mRNA and reduce the production of tau.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results